The influence of O2 on exercise capacity (6-minute-walking-distance, 6MWD) in COPD

I. Heinzelmann, A. Jerrentrup, C. Vogelmeier, K. Kenn (Schoenau am Koenigssee, Marburg, Germany)

Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Heinzelmann, A. Jerrentrup, C. Vogelmeier, K. Kenn (Schoenau am Koenigssee, Marburg, Germany). The influence of O2 on exercise capacity (6-minute-walking-distance, 6MWD) in COPD. Eur Respir J 2011; 38: Suppl. 55, 2996

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015

The effect of non-invasive ventilation (NIV) during exercise on inspiratory capacity (IC) and endurance time (Tlim) in patients with severe COPD
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019

Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Reduced submaximal exercise performance in COPD patients at moderate altitude (2590m)
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014

Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 76s
Year: 2007

Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008


Relationships between changes in the respiratory distress level of COPD patients undergoing a six-minute walking distance test, their physical functions, and exercise capacity
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013


Is a double 6-minute walk test (6MWT) required as part of the routine assessment of pulmonary rehabilitation (PR) in COPD patients?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


Why do COPD patients improve six minute walking distance (6MWD) with the use of a rollator?
Source: Eur Respir J 2003; 22: Suppl. 45, 330s
Year: 2003

Effects of exercise training on quality of life and 6 minute walk distance (6MWD) in adults with fixed airway obstruction asthma (FAOA)
Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Year: 2008

Effects of sildenafil on 6-minute walk distance (6MWD) and WHO functional class (FC) in pulmonary arterial hypertension (PAH) patients after 1 year of treatment
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Determinants of cardio-pulmonary exercise test (CPET) and shuttle walking test (SWT) in COPD patients are different
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Influence of changes in physical activity (PA) and exercise capacity on mortality and quality of life (QL) in COPD
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019


Is inspiratory capacity (IC) better correlated with functional exercise capacity than FEV1 in COPD patients?
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012


Can diagnostic staff (DS) or patients predict whether the 6-minute walk distance (6MWD) will improve to a relevant extent at a repeated 6-minute walk test (R-6MWT)?
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015


Analysis of oxygen saturation (O2 sat.) During the six minutes walk distance (6MWD) test in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009

Relationship between IL-6 and FEV1 interaction and six minute walk distance (6MWD) performance in COPD patients
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008


The impact of Symkevi (Tezacaftor/Ivacaftor) on exercise capacity in adolescents with CF
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021


Influence of hospitalizations because of COPD exacerbation in the six-minute walk test (6MWT)
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


6-minute walk test (6MWT) and Sit-to-Stand Test (STST) as outcome parameters in pulmonary rehabilitation (PR) of COPD patients
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015